Inventor · disambiguated record
Dimitri Semizarov
Also filed as: SEMIZAROV DIMITRI · SEMIZAROV DIMITRÍ
11 granted patents·9 pending applications·19 citations·filing 2006–2016
84Inventor score
Top patents by PatentIndex Score
20 records- 0191US10047403B2Diagnostic methods for determining prognosis of non-small cell lung cancerABBOTT MOLECULAR INC·Filed 2016·Granted Aug 14, 2018·5 cites·11 claims
- 0278US9291625B2Diagnostic methods for determining prognosis of non-small cell lung cancerSEMIZAROV DIMITRI·Filed 2010·Granted Mar 22, 2016·3 cites·11 claims
- 0376US8748108B2Biomarkers for identifying patient classesMCKEEGAN EVELYN M·Filed 2011·Granted Jun 10, 2014·6 cites·9 claims
- 0476US8498822B2Genomic classification of colorectal cancer based on patterns of gene copy number alterationsSEMIZAROV DIMITRI·Filed 2009·Granted Jul 30, 2013·1 cites·9 claims
- 0576US8498820B2Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterationsSEMIZAROV DIMITRI·Filed 2009·Granted Jul 30, 2013·1 cites·9 claims
- 0662US9002653B2Methods for assembling panels of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositionsSEMIZAROV DIMITRI·Filed 2009·Granted Apr 7, 2015·3 cites·5 claims
- 0759US8498821B2Genomic classification of malignant melanoma based on patterns of gene copy number alterationsSEMIZAROV DIMITRI·Filed 2009·Granted Jul 30, 2013·0 cites·9 claims
- 0854US2017096714A1Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancerABBOTT MOLECULAR INC·Filed 2016·Application pending·0 cites
- 0951US2008269067A1Companion diagnostic assays for cancer therapyABBOTT LAB·Filed 2007·Application pending·0 cites
- 1050US2008160545A1Pro-GRP as a surrogate marker to predict and monitor response to Bcl-2 inhibitor therapyABBOTT LAB·Filed 2006·Application pending·0 cites
- 1149US2010184026A1Companion Diagnostic Assays For Endothelin Receptor AntagonistsABBOTT LAB·Filed 2009·Application pending·0 cites
- 1247US9752196B2Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancerPESTOVA EKATERINA·Filed 2010·Granted Sep 5, 2017·0 cites·11 claims
- 1347US8742083B1Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263SEMIZAROV DIMITRI·Filed 2010·Granted Jun 3, 2014·0 cites·9 claims
- 1445US9297045B2Diagnostic methods for determining prognosis of non-small cell lung cancerSEMIZAROV DIMITRI·Filed 2010·Granted Mar 29, 2016·0 cites·9 claims
- 1545US2012135429A1Pro-grp as a surrogate marker to predict and monitor response to bcl-2 inhibitor therapyMCKEEGAN EVELYN M·Filed 2011·Application pending·0 cites
- 1645US2015211075A1Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancersABBVIE INC·Filed 2015·Application pending·0 cites
- 1744US2008102451A1Companion diagnostic assays for endothelin receptor antagonistsABBOTT LAB·Filed 2006·Application pending·0 cites
- 1842US9045800B2Methods and compositions for identifying, classifying and monitoring subject having Bcl-2 family inhibitor-resistant tumors and cancersSEMIZAROV DIMITRI·Filed 2010·Granted Jun 2, 2015·0 cites·22 claims
- 1942US2016160298A1Diagnostic methods for determining prognosis of non-small cell lung cancerABBOTT LAB·Filed 2016·Application pending·0 cites
- 2038US2010196907A1Markers to predict and monitor response to aurora kinase b inhibitor therapyABBOTT LAB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dimitri Semizarov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →